Glucagon

GI/Bone/Other

Evidence grade

AFDA-approved Rx (labeled use)

Cardiovascular · 0–5 · separate axis

PurposeEndocrine / Emergency

MechanismRaises blood glucose via hepatic glycogenolysis

EffectsRaises blood glucose via hepatic glycogenolysis

DosingNo human dose established.

Bottom lineStrongest data when used for its labeled indication under clinician guidance.

Batches on filenone

No tested batches on file.

Read with10

Cautions & interactions

Nausea/vomiting; effectiveness depends on glycogen stores

No well-established interaction profile for non-approved peptides; avoid combining multiple research compounds; discuss meds with clinician.

CV 3 of 5 — Clinically important in acute care settings; not a chronic 'heart health' therapy.